• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    4.90 Up 0.01(0.20%) 3:59PM EST
    |After Hours : 4.90 0.00 (0.00%) 4:50PM EST
    Add to Portfolio
    Prev Close:4.89
    Open:4.83
    Bid:N/A
    Ask:5.25 x 3000
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:4.79 - 5.01
    52wk Range:3.04 - 5.44
    Volume:715,884
    Avg Vol (3m):703,105
    Market Cap:456.35M
    P/E (ttm):N/A
    EPS (ttm):N/A
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 0.20%456.35M
    BIIBDown 1.26%84.52B
    GSKDown 0.07%108.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):98.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.48
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback